US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

41.48

+1.814.56%

Post-market: 41.480.00000.00%19:38 EDT

Volume:254.55K

Turnover:10.50M

Market Cap:259.25M

PE:- -

High:41.49

Open:40.08

Low:40.08

Close:39.67

52wk High:41.49

52wk Low:22.12

Shares:6.25M

Float Shares:6.25M

Volume Ratio:2.18

T/O Rate:4.07%

Dividend:0.28

Dividend Rate:0.68%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100

Sagimet Biosciences advances AURORA clinical trial

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

Binance launches 5 stock perpetuals with 20x leverage

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Savara announces presentations of Results from Phase 3 trial of Molgramostim

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

U.S. Stocks on the MOVE-Jersey Mike's Sub, Moderna, PDD Holding

BriaCell advances melanoma immunotherapy vaccine candidate Bria-MEL+

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Barclays Adjusts Price Target on Moderna to $125 From $48

MT Newswires Live

Moderna price target raised to $125 from $48 at Barclays

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IDNA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":41.48,"timestamp":1787688000000,"preClose":39.67,"halted":0,"volume":254554,"hourTrading":{"tag":"盘后","latestPrice":41.48,"preClose":41.48,"latestTime":"19:38 EDT","volume":175,"amount":7299.68,"timestamp":1787701127157,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.045626417948071464,"floatShares":6250000,"shares":6250000,"eps":0,"marketStatus":"Not Yet Opened","change":1.81,"latestTime":"08-25 16:00:00 EDT","open":40.08,"high":41.49,"low":40.08,"amount":10495342.87728,"amplitude":0.035543,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":39.67,"sharesOutstanding":5100000,"nav":39.56427,"aum":247276687.5,"dividendRate":0.006791,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.67,"preClose":39.67,"latestTime":"08:37 EDT","volume":1,"amount":39.67,"timestamp":1787661434513,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":41.48,"preClose":41.48,"latestTime":"19:38 EDT","volume":175,"amount":7299.68,"timestamp":1787701127157,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.179796,"impliedVol":0.091,"impliedVolPercentile":0.1275},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.179796,"shares":6250000,"dividePrice":0.2817,"high":41.49,"amplitude":0.035543,"preClose":39.67,"low":40.08,"week52Low":22.12,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":41.48,"eps":0,"divideRate":0.006791,"volume":254554,"delay":0,"ttmEps":0,"open":40.08,"prevYearClose":26.19,"prevWeekClose":40.08,"prevMonthClose":32.33,"prevQuarterClose":33.75,"fiveDayClose":35.98,"twentyDayClose":32.4473,"sixtyDayClose":29.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662737518","title":"After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737518","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662737518?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:00","pubTimestamp":1787662814,"startTime":"0","endTime":"0","summary":"WSW, NY, August 25th, 2026, FinanceWire Moderna’s cancer news sent its stock up 177% in a single day (NASDAQ:MRNA), from $62.96 to $174.38. Roughly...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/after-modernas-44b-oncology-win-silexions-pancreatic-cancer-treatment-is-worth-exploring-nasdaq-slxn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/after-modernas-44b-oncology-win-silexions-pancreatic-cancer-treatment-is-worth-exploring-nasdaq-slxn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IDNA","QQQM","QQQJ","BK4548","MNQmain","FTEC","QQQE","JEPQ","ONEQ","QYLG","LGHT","QLD","GPIQ","NDX","BK4551","QQQA","SLXN","QDTE","MRNA","BK4588","GNOM","BK4568","SQQQ","WDNA","QQQ","MRNX","BK4585","NQmain",".IXIC","TECS","MRNY","BK4501","PSQ","QID","BK4532","TQQQ","BK4534","TQQY","IYW","NVIW.SI","BK4533","QQQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732058","title":"Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732058","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732058?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:55","pubTimestamp":1787662500,"startTime":"0","endTime":"0","summary":"President & CEO, Sabrina Martucci Johnson, discusses the Company's shift to commercial stage, upcoming revenue opportunities, Ovaprene's positive interim Phase 3 results and what could drive value ove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIB","03160","BK4585","HYLG","IDNA","BK4588","GDOC","BK4555","BK4584","DARE","BK4099","BK4604","MEDX","LABU","BK4007","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732665","title":"RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732665","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732665?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661000,"startTime":"0","endTime":"0","summary":"PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350436/0/en/renovorx-highlights-peer-reviewed-publication-of-pharmacokinetic-and-pharmacodynamic-pk-pd-data-supporting-tamp-platform-s-targeted-drug-delivery-in-locally-advanced-pancreatic-can.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B66KJ199.SGD","LABU","PK","LU2931357623.SGD","BK4023","RNXT","AEIS","BK4588","LU1815336091.USD","BK4139","BK4181","IE00B19Z4B17.USD","LU2089985449.USD","LU0274383776.USD","KBWY","LU1169589451.USD","BK4017","LU0345780281.USD","IE0031619046.USD","LU0345780521.USD","MEDX","BK4585","GDOC","IE00B7SZL793.SGD","IAG","BK4218","HYLG","PD","BK4157","NVIB","LU1169590202.USD","BK4183","IE0009354923.USD","IDNA","ODD","LU0757428866.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662873429","title":"GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100","url":"https://stock-news.laohu8.com/highlight/detail?id=2662873429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662873429?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:15","pubTimestamp":1787660116,"startTime":"0","endTime":"0","summary":"Lokahi Therapeutics, a subsidiary of Glucotrack (GCTK), announced that it has started its initial Good Manufacturing Practice, GMP, manufacturing c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/glucotrack-subsidiary-initiates-clinical-trial-manufacturing-for-lt-100-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/glucotrack-subsidiary-initiates-clinical-trial-manufacturing-for-lt-100-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HYLG","BK4082","NVIB","GCTK","IDNA","GDOC","MEDX","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662773162","title":"Sagimet Biosciences advances AURORA clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662773162","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662773162?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:40","pubTimestamp":1787658027,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) announced that its AURORA Phase 3 clinical trial of FASN inhibitor denifanstat in moderate to severe acne is on track to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-advances-aurora-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-advances-aurora-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","BK4139","HYLG","SGMT","IDNA","NVIB","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662336117","title":"Moderna upgraded to Peer Perform from Underperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662336117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662336117?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:46","pubTimestamp":1787651170,"startTime":"0","endTime":"0","summary":"Wolfe Research upgraded Moderna (MRNA) to Peer Perform from Underperform without a price target The firm says the positive melanoma trial de-risks ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-upgraded-to-peer-perform-from-underperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-upgraded-to-peer-perform-from-underperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","GNOM","IDNA","MRNA","BK4585","BK4532","BK4534","BK4568","WDNA","LGHT","BK4548","MRNX","BK4533","BK4551","MRNY","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781125","title":"Binance launches 5 stock perpetuals with 20x leverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781125","media":"cryptonews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662781125?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:21","pubTimestamp":1787642512,"startTime":"0","endTime":"0","summary":"Binance Futures launched five USDT-margined TradFi perpetual contracts on Aug. 25, giving eligible traders leveraged exposure to Trump Media, Moderna and three semiconductor-focused exchange-traded funds.Binance launched five USDT margined perpetual contracts tied to U.S. stocks and leveraged exchange-traded funds.Contracts offer up to 20x leverage, round-the-clock trading and eight-hour funding settlements through Binance Futures.SKUU and SKDD track daily moves in SK Hynix, while RAM references leveraged DRAM exposure.DJT and MRNA perpetuals reference Trump Media and Moderna shares without granting stock ownership rights.Each contract uses USDT for settlement and requires a minimum notional trade worth five dollars.The contracts began trading at five-minute intervals between 09:00 and 09:20 UTC. Binance listed SKUUUSDT, SKDDUSDT, RAMUSDT, DJTUSDT and MRNAUSDT with maximum leverage of 20x.The long fund seeks twice the daily percentage change in SK Hynix’s U.S.-listed depositary receipt","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/binance-launches-5-stock-perpetuals-with-20x-leverage/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/binance-launches-5-stock-perpetuals-with-20x-leverage/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["07709","DRAL","MRNX","BK4534","BK4139","BK4568","SK","SKHU","BK4516","SKHA","DJT","BK4547","LGHT","RAMZ","BK4532","SKUU","MRNA","HYNX","TRUMP.USD.CC","WDNA","BK4077","DJTU","SKHX","DRAM","BK4548","BK4551","SKDD","BK4588","SKHZ","IDNA","BK4533","GNOM","MRNY","BK4501","SKHY","RAM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662786682","title":"Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662786682","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662786682?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:37","pubTimestamp":1787632638,"startTime":"0","endTime":"0","summary":"Viavi Solutions (VIAV) has launched Vertex 6.0, a new version of its channel emulation platform designed for 6G and Wi-Fi 7/8 testing. Investors are assessing what this expanded wireless testing capability might imply for the stock.\nSee our latest analysis for Viavi Solutions.\nThe Vertex 6.0 launch arrives after a sharp pullback in Viavi Solutions' share price, with the stock down 20.13% over the past week and 31.31% over 90 days. However, year to date the share price return is 103.58% and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1093756325.SGD","LU2089984988.USD","SG9999013999.USD","IE0009355771.USD","BK4020","IE00B19Z3581.USD","LU2065169927.USD","IE00B4R5TH58.HKD","BK4023","LU1559883803.SGD","LU2065171311.SGD","LU2362541273.HKD","IBB","VIAG","LU2236285917.USD","LU0289739699.SGD","TBXU","IE00B894F039.SGD","LU1093756168.USD","IDNA","BIB","LU2468319806.SGD","LU0240877869.USD","PBE","IE00B19Z9P08.USD","IE0002141913.USD","BK4567","IE00BZ9MQY76.HKD","LU2237438978.USD","VERX","LU2362540622.SGD","IBBQ","BBH","IE00BFTCPJ56.SGD","LU1585245621.USD","GNMX","LU2417539215.USD","LU0079474960.USD","LU1069344957.HKD","LU1778281490.HKD","LU2462157665.USD","IE00BJJMRZ35.SGD","VIAV","BK4139","LU0234570918.USD","LU0757428866.USD","IE0002270589.USD","LU2065170008.USD","LU0205194284.USD","VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137520507","title":"Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning","url":"https://stock-news.laohu8.com/highlight/detail?id=1137520507","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137520507?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:02","pubTimestamp":1787630523,"startTime":"0","endTime":"0","summary":"The biotechnology industry is fundamentally driven by clinical milestones—the success or failure of a Phase 3 trial can trigger significant share price swings not only for the companies directly...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","ARTY","BK4501","BK4588","BK4139","MRNX","BK4532","159646","BK4551","MRNY","BK4534","BK4533","MRNA","BK4585","IDNA","BK4568","BK4548","LGHT","XLK","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820617","title":"Moderna Inc. Stock Slides 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 4.3% to $138.89 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the NASDAQ Composite Index falling 0.8% to 25,980.19.Moderna Inc. closed 21.4% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.0% to $273.04, Pfizer Inc. fell 0.4% to $27.97, and Gilead Sciences Inc. rose 0.42% to $146.74.Trading volume totaled 31.3 million, compared to the 50-day average of 14.7 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","IE00B3T34201.USD","MRNX","BK4548","SG9999015952.SGD","BK4568","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0114720955.EUR","BIB","IBBQ","MRNY","BBH","SG9999015986.USD","LU2468319806.SGD","LU0122379950.USD","IE0002270589.USD","LU1037948897.HKD","GNOM","BK4566","LU1839511570.USD","LU2357627491.SGD","LU1037948541.HKD","MRNA","LU0320765992.SGD","LU2089984988.USD","WDNA","LU1061106388.HKD","BK4532","LU1585245621.USD","LU0965509283.SGD","BK4534","LU0109394709.USD","LU1934455277.USD","IE00B19Z3581.USD","MEDI","LU0289739699.SGD","BK4578","LU2324357040.USD","TBXU","IDNA","LU0234570918.USD","IBB","BMED","BK4139","LU1057294990.SGD","LU0859254822.USD","TMED","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206573","title":"Savara  announces presentations of Results from Phase 3 trial of Molgramostim","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206573","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206573?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:10","pubTimestamp":1787602218,"startTime":"0","endTime":"0","summary":"Savara (SVRA) announced the acceptance of one oral presentation and two poster presentations on data from the Phase 3 IMPALA-2 clinical trial at th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/savara-announces-presentations-of-results-from-phase-3-trial-of-molgramostim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/savara-announces-presentations-of-results-from-phase-3-trial-of-molgramostim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","IDNA","BK4139","BBC","SVRA","MEDX","NVIB","PSIL","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205703","title":"Oruka Therapeutics Names Todd Edwards Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205703","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205703?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601676,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics names Todd Edwards chief commercial officerOruka Therapeutics named Todd Edwards chief commercial officer, effective Aug. 24, 2026.Edwards joins from Arcutis Biotherapeutics, where ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL6VDQwY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1291159041.SGD","IDNA","INCY","LU0098860793.USD","LU0965508806.USD","LU2210150020.SGD","LU0820561909.HKD","LU1057294990.SGD","TRUH","LU1496350502.SGD","LU0211327993.USD","IE00B2B36J28.USD","IYH","RXL","FHLC","ARQT","LU2210149790.SGD","BCDF","LU2125909247.SGD","LU0395794307.EUR","LU1718418525.SGD","LU2347655156.SGD","PPH","JDOC","LU2357627491.SGD","IXJ","VHT","SG9999015945.SGD","IE00BN0W2W23.USD","IE00B3PB1722.GBP","LU1934455277.USD","FTXH","LU2129689431.USD","BK4550","LU0689626769.HKD","LU1923622614.USD","LU0124676726.USD","NDAQ","GLAM","LU0456855351.SGD","XLV","LU0738911758.USD","LU1551013342.USD","SG9999014021.USD","AGNG","MEDX","PJP","ORKA","ABBV","LU0949170772.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035552","title":"Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035552","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035552?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:15","pubTimestamp":1787591724,"startTime":"0","endTime":"0","summary":"• Moderna and Merck announced positive Phase 3 results for their personalized mRNA cancer vaccine.\n• The stock surged significantly before experiencing a pullback driven by profit-taking and valuation resets.\n• Analysts maintained cautious ratings and price targets well below the temporary peak levels.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262128327-market-movers-mrna-20260824","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4532","BK4548","BK4139","BK4588","BK4501","BK4568","MRNA","MRNX","MRNY","WDNA","BK4585","BK4551","BK4533","IDNA","LGHT","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661285272","title":"Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661285272","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661285272?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:45","pubTimestamp":1787582700,"startTime":"0","endTime":"0","summary":"Top executives at Moderna have been projecting high confidence in the commercial future of the company's personalized cancer vaccine even as Wall Street holds out for complete trial results.The market","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044865.SGD","BK4501","IDNA","IXJ","HRTS","IHE","BMED","LU2491050154.USD","LU0211331839.USD","FTXH","VHT","LU0208291251.USD","LU0234572021.USD","MRK","WDNA","RXL","LU0238689110.USD","LU2361045086.USD","IE00BN8TJ469.HKD","BK4568","LU0868494708.USD","MRNX","LGHT","RCC","LU1917777945.USD","LU0203347892.USD","LU1037948541.HKD","LU0320765489.SGD","PPH","TRUH","MRNY","GDOC","LU0124676726.USD","BK4585","LU1989772923.USD","PAWZ","LU1116320737.USD","GNOM","IE00BJT1NW94.SGD","BK4532","LU0058720904.USD","MRNA","XLV","JDOC","FHLC","IYH","SG9999015358.SGD","BK4139","LU2324357040.USD","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","HELX","GNMX","GNOM","IDNA","IBB","PBE","MEDX","HTEC","XT","FDIF","BMED","LFSC","BK4585","SYNB","WDNA","JDOC","TMAT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661827943","title":"U.S. Stocks on the MOVE-Jersey Mike's Sub, Moderna, PDD Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2661827943","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661827943?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:58","pubTimestamp":1787576301,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Jersey Mike's Sub, Moderna, PDD HoldingAugust 24 (Reuters)-Wall Street futures slipped on Monday as concerns over the U.S. pledge of an \"economic D-Day\" against Iran kept ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL6N44L0LA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4553","IE00B775SV38.USD","LU0056508442.USD","LU0683595622.HKD","HK0000320264.USD","LU2326559502.SGD","LU0077335932.USD","LU0348788117.USD","LU0348825331.USD","LU0985320562.USD","LU1815336760.USD","LU1242518931.SGD","LU0820561818.USD","LU1116320737.USD","IE0031814852.USD","LU2065170008.USD","SLX","LU0642271901.SGD","SGXZ99366536.SGD","LU0047713382.USD","IE00B3SWFQ91.USD","VGT","BK4585","LU0979878070.USD","LU0096362180.USD","LU2347655073.USD","LU2244417387.USD","BK4543","IE00BHPRN162.USD","LU2290526834.HKD","LU1037948897.HKD","LU2361044865.SGD","SGXZ51526630.SGD","LU2097344357.USD","GB00BDT5M118.USD","LU0127658192.USD","LU1633808545.USD","BK4587","LU1035775433.USD","NVDL","IE00BYXW3230.USD","LU0965509101.SGD","LU1861215975.USD","SG9999018857.SGD","LU0265550946.USD","LU0310800379.SGD","NVDA","LU2592432038.USD","LU2236285917.USD","BK4549","LU0345770993.USD","LU0737861772.HKD","SG9999014559.SGD","LU0345768740.USD","LU0557290698.USD","LU1244550221.USD","IE00BMPRXQ63.HKD","LU0053666078.USD","LU0823039010.USD","LU1048596156.SGD","LU1808992512.USD","BK4529","IE00B19Z8W00.USD","LU0444973449.USD","NVDQ","LU0320765059.SGD","LU0370786039.SGD","LU2168564495.EUR","BK4554","LU1242518857.USD","LU2133065610.SGD","KPDD","LU0390134368.USD","LU1127390331.HKD","IE000KEQY171.SGD","LU1923623000.USD","LU2108987350.USD","LU0211328371.USD","IE00BZ1G4Q59.USD","LU0823038988.USD","LU2279689827.SGD","BK4533","LU2279858448.HKD","LU0307460666.USD","LU0456827905.SGD","LU2860962120.EUR","LU0942090050.USD","BK4568","LU2023251221.USD","LU0267386448.USD","LU0289961442.SGD","LU1145028129.USD","LU0661504455.SGD","IE00BJLML261.HKD","ROM","LU2242649171.HKD","IE000ITXATA3.USD","LU0957791311.USD","LU2756315664.SGD","LU0330918003.SGD","LU0868494617.USD","LU2473716301.USD","LU0203201768.USD","LU0061474960.USD","LU2242650005.HKD","SG9999014567.USD","LU0347712357.USD","LU0456846285.SGD","BK4509","MAX","LU1202635105.USD","LU2931357623.SGD","LU2237443895.HKD","LU2125909247.SGD","SG9999002224.SGD","LU0096364046.USD","LU1171460220.USD","PYZ","IE00B29SXG58.USD","LU0889565833.HKD","LU2168564065.EUR","LU2028103732.USD","LU0198837287.USD","LU1934455194.USD","CMAG","BK4550","LU0353189763.USD","LU2322448957.HKD","CHAT","LU0070217475.USD","LU0234572021.USD","LU2471134879.HKD","LU1023057109.AUD","LU0049112450.USD","LU2063271972.USD","LU1720051108.HKD","LU1880383440.USD","BK4581","LU1935042215.USD","LU0069063385.USD","NVDX","LU2458330169.SGD","LU0531971595.HKD","LU0605514214.HKD","LU2065169927.USD","LU2089283258.USD","LU1571399168.USD","LU0823414551.USD","LU1400636574.HKD","IE00BN29S564.USD","ARTY","TYLG","LU2458330243.SGD","BK4567","BK4592","AIPI","LU2125909916.SGD","LU0545039389.USD","NVDS","BK4612","LU0589944569.HKD","IE0004086264.USD","LU0143863784.USD","LU2125909759.SGD","LU1119994496.HKD","LU1046422090.SGD","LU2264538146.SGD","LU0957808578.USD","LU2552382132.HKD","NUE","LU0211327993.USD","LU0786609619.USD","LU1989772840.SGD","BK4531","LU2462157665.USD","LU0081259029.USD","LU1303224171.USD","LU1048588211.SGD","LU0011850046.USD","LU1914381329.SGD","SG9999018865.SGD","LU1935043536.SGD","LU2250418816.HKD","LU1794554557.SGD","LU2023250330.USD","IE00BD6J9T35.USD","SG9999002828.SGD","LU1232071149.USD","LU1699723380.USD","LU2237443978.SGD","BK4551","BK4006","LU0079474960.USD","LU1917777945.USD","LU0225283273.USD","NVDS.UK","IE00B19Z9505.USD","LU1803068979.SGD","LU2954938101.SGD","LU1035773651.USD","CENX","LU1935042488.USD","IE00B19Z8X17.USD","IE000Q6AESB8.SGD","SG9999014880.SGD","SG9999004303.SGD","LU2237443382.USD","EFIV","LU0140636845.USD","LU2357125470.USD","IE00BFSS7M15.SGD","IE0001KFT4U8.USD","LU0345769128.USD","LU1023059493.AUD","LU0882574139.USD","SG9999014575.USD","LU0516423091.SGD","2NVD.UK","IE00B7KXQ091.USD","LU2637965513.SGD","NVD2.UK","NVDW","SG9999014674.SGD","LU2168564149.EUR","LU2361045086.USD","IE00BWXC8680.SGD","LU0633140560.USD","LU1720050803.USD","LU2211817866.USD","LU1719994722.HKD","LU1721428933.USD","LU0823413587.USD","LU0708995583.HKD","LU0787776722.HKD","LU1718418525.SGD","LU1066053197.SGD","LU0154236417.USD","LU0359201885.HKD","LU0234570918.USD","IE00B5TLWC47.USD","LU0417516902.SGD","LU2125154935.USD","LU0588546209.SGD","LU2381873111.SGD","LU2471134796.USD","LU1769817179.HKD","LU2462591350.SGD","SGXZ23171101.USD","LU2506951792.HKD","LU1868837136.USD","LU2272731865.HKD","LU0672654240.SGD","CNEQ","SG9999014542.SGD","IE00BJTD4V19.USD","LU0061475181.USD","LU1934455863.HKD","LU2750360641.GBP","LU1066051498.USD","LU0820561909.HKD","LU2271345857.HKD","LU0502904849.HKD","LU2047632596.USD","SNVDAmain","IE0009G5SDU7.USD","LU0964807845.USD","LU0210528500.USD","LU0061474705.USD","LU0057025933.USD","LU1934455277.USD","LU0572944931.SGD","LU2491049909.HKD","BK4598","LU0329678170.USD","LU0117841782.USD","LU0476273544.USD","LU1868837565.USD","LU0124676726.USD","LU0788109121.HKD","LU1988902786.USD","BK4077","LU1974910355.USD","LU2896262040.SGD","AIFD","LU0943347566.SGD","LU2487616109.SGD","LU0107464264.USD","LU0738911758.USD","LU2357305700.SGD","IE00BMPRXN33.USD","IE00BQXX3D17.EUR","SHOC","LU2360032135.SGD","LU0154245673.USD","XLK","LU2213496289.HKD","IE00B3M56506.USD","LU2756315318.SGD","LU0175139822.USD","LU2505996509.AUD","MRNA","WDNA","LU0329678337.USD","NVIW.SI","LU0276348264.USD","LU0128525929.USD","LU1069347547.HKD","IE0005OL40V9.USD","LU0082616367.USD","GAMR","MRNY","3NVD.UK","LU0912757837.SGD","IE00BK4W5L77.USD","LU0075056555.USD","BK4209","SMHX","ESLG","LU0795875086.SGD","LU1880398554.USD","LU1880398471.USD","LU2420271590.USD","LU1791710400.SGD","LU0256863811.USD","LU1261432733.SGD","LU2023250504.SGD","LU1251922891.USD","LU0158827948.USD","LU0683600562.USD","LU1935042991.SGD","LU1935043023.USD","HK0000819398.USD","LU0143551892.USD","IXN","LU2417539215.USD","WISE","LU2394011477.USD","USXF","LU0251132253.USD","LU0289960550.SGD","JMKE","LU1551013342.USD","LU0164865239.USD","LU2552382058.USD","DRAG","LU0949170772.SGD","IE00BQXX3F31.USD","LU0823397103.USD","LU0138981039.USD","LU1815333072.USD","LU2039709279.SGD","LU0823413660.USD","LU0823421416.USD","LU0080751232.USD","LU0072462343.USD","LU1983260115.SGD","LU0256863902.USD","SGXZ31699556.SGD","ONLN","LU0210526637.USD","IE00BJTD4N35.SGD","IE0004445015.USD","LU0823434740.USD","NULC","NVII","BK4548","LU2463028550.USD","IE0034235188.USD","ABFL","LU0528227936.USD","SG9999015952.SGD","LU0594300179.USD","SG9999014906.USD","LU1674673428.USD","LU2430703178.SGD","LU0516422440.USD","SG9999015945.SGD","SNVD.UK","LU1629891620.HKD","LU1868837722.USD","IE000W1ABFV2.USD","LU1989764748.USD","LU2265009873.SGD","LU2433249047.HKD","LU2111349929.HKD","LU0323240290.USD","LU0689626769.HKD","LU1153585028.USD","LU0823414478.USD","STLD","FDNI","LU1496350502.SGD","LU1981816686.USD","LU0203202063.USD","LU1880383366.USD","LU1244550494.USD","IE0034235303.USD","BK4122","LU0708994859.HKD","LU2087589342.USD","SG9999015358.SGD","LU2430703095.HKD","LU2237957811.SGD","LU2272731600.USD","BK4141","LU0109392836.USD","LU1839511570.USD","LU0215105999.USD","LU2065171402.SGD","LU0231483743.USD","LU2347655156.SGD","SOXQ","LU2237443465.HKD","LU0048584097.USD","IE00BMPRXR70.SGD","IE00BKDWB100.SGD","SGXZ80539844.SGD","NVDO","PICK","BK4516","LU2087621335.USD","IE00B1XK9C88.USD","IE00BGV7N243.SGD","LU0170899867.USD","LU0965509283.SGD","LU1551013425.SGD","IE00B775H168.HKD","LU0689472784.USD","LU0327786744.USD","LU1712237335.SGD","IE0003U64NQ7.SGD","LU1989764664.SGD","LU2999663052.SGD","LU1267930730.SGD","LU2097344431.USD","LU0823421333.USD","LU0029864427.USD","LU0097036916.USD","LU0633140727.USD","ILDR","LU1623119135.USD","LU2413666426.HKD","LU2089985449.USD","LU1645745479.HKD","BK4532","IE00BJJMRX11.SGD","LU0726765562.USD","MRNX","LU0878005551.USD","LU1116320901.HKD","IE00BFSS8Q28.SGD","LU0724617625.USD","LU0823426480.USD","LU1923622614.USD","PDD","BK4605","LU0109391861.USD","SOXY","LU0174119429.USD","HK0000320223.HKD","LGHT","LU2054465674.USD","LU0345770308.USD","LU1868838027.USD","SG9999001424.SGD","LU0052750758.USD","LU1674673691.USD","BK4534","HK0000914686.HKD","07388","LU1804176565.USD","LU1852331112.SGD","LU1868837300.USD","LU1951198990.SGD","LU2543165471.USD","SMH","SG9999015986.USD","LU1923622291.USD","LU0048580855.USD","LU2361044949.HKD","IE00BKVL7J92.USD","LU0359202008.SGD","THMR","LU1720051017.SGD","LU1642822529.SGD","TTEQ","IE00BZ199S13.USD","LU2272731782.SGD","IE00BK4W5M84.HKD","LU1235295612.USD","BK4504","LU2083900584.USD","LU0133085943.USD","LU2092627202.USD","LU2125909593.SGD","LU2257852520.SGD","NVD","LU2746668461.USD","LU1548497426.USD","IDNA","LU0157215616.USD","LU0289739343.SGD","LU0308772762.SGD","PDDL","LU0274383776.USD","LU0444971666.USD","ANV","LU0328353924.USD","LU0965508806.USD","BK4139","BK4220","LU0650527681.SGD","LU0516422952.EUR","HK0000914660.USD","LU2505996681.GBP","NVYY","LU1868836757.USD","IE0009356076.USD","HK0000306685.HKD","TEK","IE00BDRTCR15.USD","LU1316542783.SGD","LU2077746001.SGD","LU2491050154.USD","SOXX","SG9999017495.SGD","LU1400636657.SGD","LU0348827113.USD","LFGY","IE00B4YYXB79.USD","NVDY","SG9999002463.SGD","LU1066051811.HKD","LU0708995401.HKD","LU2092937148.SGD","LU2211815571.USD","BK4535","LU2177674079.SGD","LU0039217434.USD","LU2471134952.CNY","LU0553294199.USD","BK4588","LU1069344957.HKD","LU0823434583.USD","IE00BDCRKT87.USD","LU1323998911.USD","SG9999015978.USD","BK4608","LU0354030511.USD","LU0516422366.SGD","IE00B4JS1V06.HKD","BK4527","LU1821325948.USD","NVDD","LU1732799900.SGD","LU2471134523.USD","LU1003077747.HKD","SG9999014898.SGD","LU2168564222.USD","LU0323591593.USD","LU0051755006.USD","LU1429558221.USD","LU2148611432.USD","LU1732800096.USD","JGRO","LU0823426308.USD","LU0348723411.USD","LU1267930573.SGD","CLF","TTXU","LU2360107168.USD","IE0034224299.USD","LU0516423174.USD","LU2399975544.HKD","LU2750360997.AUD","LU0353189680.USD","LU1778281490.HKD","LU2430703251.USD","BK4505","LU1084165304.USD","LU2602419157.SGD","LU2125154778.USD","LU1769817096.USD","LU2461242641.AUD","LU1868836591.USD","LU0342679015.USD","LU2008162690.USD","LU2552382215.SGD","LU2106854487.HKD","ESUM","NVD3.UK","LU0561508036.HKD","IE00B3S45H60.SGD","LU2413666699.HKD","LU1144417596.USD","LU0417517546.SGD","CLIX","IE00B0JY6N72.USD","LU2237443549.SGD","FAI","LU0154245756.USD","LU0348805143.USD","LU0795875169.SGD","LU0143863198.USD","CLSE","LU0640476718.USD","LU0395794307.EUR","KWEB","LU3102509885.SGD","LU1323610961.USD","LU0719512351.SGD","NVDU","AGOX","LU0861579265.USD","USD","LU2247934214.USD","LU0494093205.USD","LU2242644610.SGD","LU1670756490.USD","GNOM","LU0210533765.USD","LU0466842654.USD","LU2322448791.USD","LU1435385759.SGD","LU1066051225.USD","LU0158827781.USD","LU0820562030.AUD","LU1280957306.USD","LU2452424414.USD","SG9999014914.USD","LU0266013472.USD","LU0868494708.USD","SG9999000418.SGD","IE0004091025.USD","LU0345769631.USD","LU0511384066.AUD","LU1064131342.USD","LU1868836914.USD","IE000YTNTUN2.SGD","LU0259732245.USD","DIPS","LU1992135472.HKD","LU2294711713.HKD","METV","LU2237438978.USD","BK4153","BK4614","LU2100268510.USD","VT","LU1037948541.HKD","LU2462591277.SGD","SNPE","LU0235996351.USD","CHPX","HK0000304805.HKD","LU0238689110.USD","SG9999002562.SGD","LU2456880835.USD","HK0000304797.USD","LU0788109477.HKD","LU1961090484.USD","LU2491050071.SGD","LU0821914370.USD","NVDB","IE00B5949003.HKD","SG9999002232.USD","BK4558","LU1979441026.SGD","LU2746668974.SGD","LU1366333091.USD","LU2360106780.USD","LU0006306889.USD","NVDG","LU0455707207.USD","LU1770034418.SGD","BK4501","LU2249611893.SGD","BK4526","IE00BQXX3C00.GBP","SG9999015341.SGD","LU0315179316.USD","LU1861220033.SGD","LU2286300806.USD","BK4579","LU1496350171.SGD","FDTX","SPTE","FTEC","LU1992135399.USD","LU0345768153.USD","LU2168563687.JPY","LU2087625088.SGD","IE00B1BXHZ80.USD","LU0965509010.AUD","LU1366192091.USD","LU0359201612.USD","LU0320764599.SGD","NVC","LU2237443622.USD","LU1691799644.USD","LU0354030438.USD","IETC","LU0316494557.USD","07788","IE0034235295.USD","LU1244550577.SGD","LU0594300419.USD","HK0000532082.HKD","LU0871576103.HKD","LU2065171311.SGD","IE00BJJMRY28.SGD","LU1951200564.SGD","TRFK","IE00BKPKM429.USD","LU0310799852.SGD","LU0823397285.USD","LU1267930490.SGD","LU2237957902.USD","LU1400636491.USD","LU1989772923.USD","LU2191332357.HKD","LU0472753341.HKD","LU0072462426.USD","LU1956131251.USD","BK4503","SGXZ81514606.USD","LU0187121727.USD","LU2403377893.USD","IE0004445239.USD","LU0094547139.USD","LU0323239441.USD","LU2089284900.SGD","HK0000306701.USD","LU0106261372.USD","LU1814569148.SGD","LU1861127337.USD","LU0210536198.USD","LU1791710582.SGD","LU0265550359.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275154","title":"BriaCell advances melanoma immunotherapy vaccine candidate Bria-MEL+","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275154","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275154?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:35","pubTimestamp":1787571306,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) announced that Bria-MEL+, its personalized whole cell melanoma immunotherapy vaccine candidate, has achieved a genetic engineering ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-advances-melanoma-immunotherapy-vaccine-candidate-bria-mel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-advances-melanoma-immunotherapy-vaccine-candidate-bria-mel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BCTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273955","title":"Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273955","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273955?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:04","pubTimestamp":1787569487,"startTime":"0","endTime":"0","summary":"BUZZ-Barclays raises Moderna PT on 'transformative' melanoma vaccine potential** Barclays raises PT on vaccine maker ModernaMRNA.Oto $125 from $48, maintains \"equal weight\" rating** New PT implies a 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL6N44L0K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","LU0265550946.USD","LU2361044949.HKD","IE00BFTCPJ56.SGD","IHE","SG9999002232.USD","LU0965509010.AUD","IE00BSNM7G36.USD","LU0689626769.HKD","LU1093756168.USD","LU1037948897.HKD","LU1934455277.USD","LU1023059063.AUD","LU1923622614.USD","LU1037948541.HKD","SG9999014575.USD","LU1983299246.USD","IE00BN8TJ469.HKD","LU0006306889.USD","LU0098860793.USD","MRK","IE00BJJMRZ35.SGD","LU0208291251.USD","LU1035773651.USD","LU0965509283.SGD","SG9999001440.SGD","LU0266013472.USD","LU1061106388.HKD","GDOC","IE00B1BXHZ80.USD","LU0985320562.USD","LU1571399168.USD","BK4139","LU0124676726.USD","LU1934455863.HKD","IE00BLSP4452.SGD","WDNA","LU0058720904.USD","LU1066051225.USD","LU0861579265.USD","LU0265550359.USD","LU1291159041.SGD","LU0130102774.USD","LU2468319806.SGD","LU0432979614.USD","IYH","LU2125909593.SGD","LU1066053197.SGD","LGHT","LU0320765489.SGD","GNOM","LU2112291526.USD","BK4532","BK4551","LU2324357040.USD","SG9999014559.SGD","LU0477156953.USD","IXJ","IE00BJT1NW94.SGD","LU0859254822.USD","PPH","BMED","LU2023250504.SGD","LU2361045086.USD","SGXZ57979304.SGD","BK4501","BK4568","LU1162221912.USD","LU2125154778.USD","LU1941712348.USD","IE00B4R5TH58.HKD","SG9999014542.SGD","LU2491050071.SGD","SG9999014567.USD","BK4585","BK4516","LU0868494708.USD","LU0965509101.SGD","LU1585245621.USD","LU0238689110.USD","FTXH","IDNA","BK4559","IE0002141913.USD","LU1934455194.USD","MRNY","LU1941712264.USD","LU0122379950.USD","LU0203345920.USD","LU0320765646.SGD","HRTS","LU0823416689.USD","LU0648001328.SGD","LU1929549753.HKD","LU0289739699.SGD","LU0980610538.SGD","LU1699723380.USD","LU1093756325.SGD","LU0130517989.USD","BK4533","LU0234572021.USD","BK4548","LU1116320901.HKD","SG9999001176.USD","LU0965508806.USD","RXL","JDOC","SG9999002224.SGD","LU2491049909.HKD","TRUH","SG9999001176.SGD","LU1201861249.SGD","SG9999015341.SGD","LU1066051811.HKD","MRNA","LU0070302665.USD","LU1069347547.HKD","IE0009355771.USD","LU2023250843.SGD","LU1917777945.USD","LU0868494617.USD","BK4550","IE00BLSP4239.USD","LU2433249047.HKD","LU0942090050.USD","LU1989772840.SGD","LU1066051498.USD","LU1989772923.USD","LU0211331839.USD","LU1116320737.USD","BK4588","LU2106854487.HKD","XLV","LU2125154935.USD","LU1974910355.USD","PAWZ","IE000M9KFDE8.USD","LU2125909247.SGD","LU1430594728.SGD","LU2357627491.SGD","FHLC","LU2491050154.USD","LU2360032135.SGD","LU1989771016.USD","SG9999013999.USD","LU1057294990.SGD","LU0203347892.USD","IE00B2B36J28.USD","LU2089984988.USD","VHT","IE00BBT3K403.USD","LU2461242641.AUD","SG9999015358.SGD","BK4534","LU2361044865.SGD","LU0106261372.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661585278","title":"Barclays Adjusts Price Target on Moderna to $125 From $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2661585278","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661585278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:30","pubTimestamp":1787567415,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $96.47, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4568","BK4501","BK4548","BK4534","BK4551","MRNA","BK4139","BK4588","BK4585","GNOM","MRNX","WDNA","IDNA","MRNY","LGHT","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220277","title":"Moderna price target raised to $125 from $48 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220277","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661220277?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:20","pubTimestamp":1787566817,"startTime":"0","endTime":"0","summary":"Barclays analyst Eliana Merle raised the firm’s price target on Moderna (MRNA) to $125 from $48 and keeps an Equal Weight rating on the shares. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-price-target-raised-to-125-from-48-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-price-target-raised-to-125-from-48-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","IDNA","BK4501","BK4585","LGHT","BK4548","BK4534","MRNY","MRNX","BK4532","GNOM","BK4551","BK4139","MRNA","WDNA","BK4588","BK4533"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":2,"totalSize":249,"code":"91000000","status":"200"}]}}